Garv Industries IPO vs Indo US Bio-Tech IPO

Comparison between Garv Industries IPO and Indo US Bio-Tech IPO.

IPO Details

Garv Industries IPO is a SME Fixed Price IPO proposed to list at BSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Garv Industries IPO is up to ₹3.03 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Garv Industries IPO is ₹10.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.

 Garv Industries IPOIndo US Bio-Tech IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹10.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size10000 shares2000 shares
Fresh Issue Size30,30,000 shares13,56,000 shares
Fresh Issue Size (Amount)up to ₹3.03 Crup to ₹6.92 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total30,30,000 shares13,56,000 shares
Issue Size Total (Amount)up to ₹3.03 Crup to ₹6.92 Cr

IPO Timetable

Garv Industries IPO opens on Apr 12, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Garv Industries IPO and Indo US Bio-Tech IPO is Apr 17, 2018, and May 03, 2018, respectively.

 Garv Industries IPOIndo US Bio-Tech IPO
Issue OpenApr 12, 2018Apr 30, 2018
Issue CloseApr 17, 2018May 03, 2018
Basis Of Allotment (Tentative)Apr 20, 2018May 08, 2018
Initiation of Refunds (Tentative)Apr 23, 2018
Credit of Share (Tentative)Apr 24, 2018
Listing date (Tentative)Apr 25, 2018May 11, 2018

Financials & KPIs

Garv Industries IPO P/E ratio is , as compared to Indo US Bio-Tech IPO P/E ratio of .

 Garv Industries IPOIndo US Bio-Tech IPO
Financials

Company Financials (Restated)

Period Ended31 Jan 2018
Assets10.36
Total Income14.59
Profit After Tax0.11
NET Worth6.93
Reserves and Surplus0.11
Total Borrowing0.01
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Oct 201731 Mar 201731 Mar 201631 Mar 2015
Assets20.5612.9413.697.68
Total Income15.8924.5819.1519.66
Profit After Tax0.740.650.360.50
NET Worth4.633.893.252.90
Reserves and Surplus3.142.401.771.41
Total Borrowing6.394.864.671.67
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)68.63%70.54%
Market Cap₹10.20 Cr.₹24.76 Cr.

Shares Offered

In the Garv Industries IPO Retail Individual Investors (RII) are offered 15,15,000 shares while in Indo US Bio-Tech IPO retail investors are offered 15,15,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Garv Industries IPO and 0 shares in Indo US Bio-Tech IPO.

 Garv Industries IPOIndo US Bio-Tech IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,70,000 shares74,000 shares
QIB0 shares0 shares
NII15,15,000 shares6,78,000 shares
RII15,15,000 shares6,78,000 shares
Employee0 shares0 shares
Total30,30,000 shares13,56,000 shares

Bids Received (Subscription)

Garv Industries IPO subscribed 2.13x in total, whereas Indo US Bio-Tech IPO subscribed 19.69x.

 Garv Industries IPOIndo US Bio-Tech IPO
NII (times)2.28x19.52x
RII (times)1.98x19.87x
Total (times)2.13x19.69x

Compare with others

Compare:

Garv Industries IPO Vs Indo US Bio-Tech IPO